BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21692504)

  • 1. A substrate-free activity-based protein profiling screen for the discovery of selective PREPL inhibitors.
    Lone AM; Bachovchin DA; Westwood DB; Speers AE; Spicer TP; Fernandez-Vega V; Chase P; Hodder PS; Rosen H; Cravatt BF; Saghatelian A
    J Am Chem Soc; 2011 Aug; 133(30):11665-74. PubMed ID: 21692504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of PREPl causes growth impairment and hypotonia in mice.
    Lone AM; Leidl M; McFedries AK; Horner JW; Creemers J; Saghatelian A
    PLoS One; 2014; 9(2):e89160. PubMed ID: 24586561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PREPL A protein, a new member of the prolyl oligopeptidase family, lacking catalytic activity.
    Szeltner Z; Alshafee I; Juhász T; Parvari R; Polgár L
    Cell Mol Life Sci; 2005 Oct; 62(19-20):2376-81. PubMed ID: 16143824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia-cystinuria syndrome.
    Jaeken J; Martens K; Francois I; Eyskens F; Lecointre C; Derua R; Meulemans S; Slootstra JW; Waelkens E; de Zegher F; Creemers JW; Matthijs G
    Am J Hum Genet; 2006 Jan; 78(1):38-51. PubMed ID: 16385448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome.
    Régal L; Shen XM; Selcen D; Verhille C; Meulemans S; Creemers JW; Engel AG
    Neurology; 2014 Apr; 82(14):1254-60. PubMed ID: 24610330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PREPL, a prolyl endopeptidase-like enzyme by name only?--Lessons from patients.
    Boonen K; Régal L; Jaeken J; Creemers JW
    CNS Neurol Disord Drug Targets; 2011 May; 10(3):355-60. PubMed ID: 21222627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PREPL deficiency: delineation of the phenotype and development of a functional blood assay.
    Régal L; Mårtensson E; Maystadt I; Voermans N; Lederer D; Burlina A; Juan Fita MJ; Hoogeboom AJM; Olsson Engman M; Hollemans T; Schouten M; Meulemans S; Jonson T; François I; Gil Ortega D; Kamsteeg EJ; Creemers JWM
    Genet Med; 2018 Jan; 20(1):109-118. PubMed ID: 28726805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and ultra structural evidence for cytoskeletal localization of prolyl endopeptidase-like protein in neurons.
    Morawski M; Nuytens K; Juhasz T; Zeitschel U; Seeger G; Waelkens E; Regal L; Schulz I; Arendt T; Szeltner Z; Creemers J; Rossner S
    Neuroscience; 2013 Jul; 242():128-39. PubMed ID: 23485813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolyl Endopeptidase-Like Facilitates the α-Synuclein Aggregation Seeding, and This Effect Is Reverted by Serine Peptidase Inhibitor PMSF.
    Santos GS; Oyadomari WY; Carvalho EA; Torquato RS; Oliveira V
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32630529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PREPL: a putative novel oligopeptidase propelled into the limelight.
    Martens K; Derua R; Meulemans S; Waelkens E; Jaeken J; Matthijs G; Creemers JW
    Biol Chem; 2006 Jul; 387(7):879-83. PubMed ID: 16913837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fluopol-ABPP HTS assay to identify PAD inhibitors.
    Knuckley B; Jones JE; Bachovchin DA; Slack J; Causey CP; Brown SJ; Rosen H; Cravatt BF; Thompson PR
    Chem Commun (Camb); 2010 Oct; 46(38):7175-7. PubMed ID: 20740228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia-cystinuria syndrome.
    Chabrol B; Martens K; Meulemans S; Cano A; Jaeken J; Matthijs G; Creemers JW
    J Med Genet; 2008 May; 45(5):314-8. PubMed ID: 18234729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-Golgi network morphology and sorting is regulated by prolyl-oligopeptidase-like protein PREPL and the AP-1 complex subunit μ1A.
    Radhakrishnan K; Baltes J; Creemers JW; Schu P
    J Cell Sci; 2013 Mar; 126(Pt 5):1155-63. PubMed ID: 23321636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxime esters as selective, covalent inhibitors of the serine hydrolase retinoblastoma-binding protein 9 (RBBP9).
    Bachovchin DA; Wolfe MR; Masuda K; Brown SJ; Spicer TP; Fernandez-Vega V; Chase P; Hodder PS; Rosen H; Cravatt BF
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2254-8. PubMed ID: 20207142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolyl endopeptidase-like is a (thio)esterase involved in mitochondrial respiratory chain function.
    Rosier K; McDevitt MT; Smet J; Floyd BJ; Verschoore M; Marcaida MJ; Bingman CA; Lemmens I; Dal Peraro M; Tavernier J; Cravatt BF; Gounko NV; Vints K; Monnens Y; Bhalla K; Aerts L; Rashan EH; Vanlander AV; Van Coster R; Régal L; Pagliarini DJ; Creemers JWM
    iScience; 2021 Dec; 24(12):103460. PubMed ID: 34888501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidomics of prolyl endopeptidase in the central nervous system.
    Nolte WM; Tagore DM; Lane WS; Saghatelian A
    Biochemistry; 2009 Dec; 48(50):11971-81. PubMed ID: 19911840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Fluorescence Polarization Activity-Based Protein Profiling Assay in the Discovery of Potent, Selective Inhibitors for Human Nonlysosomal Glucosylceramidase.
    Lahav D; Liu B; van den Berg RJBHN; van den Nieuwendijk AMCH; Wennekes T; Ghisaidoobe AT; Breen I; Ferraz MJ; Kuo CL; Wu L; Geurink PP; Ovaa H; van der Marel GA; van der Stelt M; Boot RG; Davies GJ; Aerts JMFG; Overkleeft HS
    J Am Chem Soc; 2017 Oct; 139(40):14192-14197. PubMed ID: 28937220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The second point mutation in PREPL: a case report and literature review.
    Silva S; Miyake N; Tapia C; Matsumoto N
    J Hum Genet; 2018 May; 63(5):677-681. PubMed ID: 29483676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxypeptidase in prolyl oligopeptidase family: Unique enzyme activation and substrate-screening mechanisms.
    Yadav P; Goyal VD; Gaur NK; Kumar A; Gokhale SM; Jamdar SN; Makde RD
    J Biol Chem; 2019 Jan; 294(1):89-100. PubMed ID: 30409909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia-cystinuria syndrome.
    Chabrol B; Martens K; Meulemans S; Cano A; Jaeken J; Matthijs G; Creemers JW
    BMJ Case Rep; 2009; 2009():. PubMed ID: 21686663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.